Loading...

Pear Therapeutics, Inc.

PEARWNASDAQ
Healthcare
Medical - Healthcare Information Services
$0.006
$0.00(0.00%)

Pear Therapeutics, Inc. (PEARW) Stock Overview

Explore Pear Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 58.4/100

Key Financials

Market Cap4.1M
P/E Ratio-0.17
EPS (TTM)$-10.10
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

PEARW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pear Therapeutics, Inc. (PEARW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.17 and a market capitalization of 4.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-94.64%
6-Month Change
-96.31%
Year-to-Date (YTD) Change
-95.09%
1-Year Change
-98.33%
3-Year Change
-99.41%
5-Year Change
-99.41%
All-Time (Max) Change
-99.41%

Contact Information

833 697 3738
200 State Street, Boston, MA, 02109

Company Facts

200 Employees
CountryUS

Frequently Asked Questions

;